{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/375646403"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "These PEGylated GLP-1 compounds and compositions are useful in treating diabetes, obesity, irritable bowel syndrome and other conditions that would be benefited by lowering plasma glucose, inhibiting gastric and/or intestinal motility and inhibiting gastric and/or intestinal emptying, or inhibiting food intake." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "radaris.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/320053813"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/375646403" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/182831061"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/375646403"] } } }
